Influence of corticosteroid treatment on CXCR4 expression in DLBCL

BACKGROUND: CXCR4-targeted radioligand therapy (RLT) with [(177)Lu]Lu/[(90)Y]Y-PentixaTher has recently evolved as a promising therapeutic option for patients with advanced hematological cancers. Given their advanced disease stage, most patients scheduled for PentixaTher RLT require concomitant or b...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Sebastian, Viertl, David, Janz, Anna, Habringer, Stefan, Keller, Ulrich, Schottelius, Margret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172459/
https://www.ncbi.nlm.nih.gov/pubmed/37162652
http://dx.doi.org/10.1186/s13550-023-00993-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172459/
https://www.ncbi.nlm.nih.gov/pubmed/37162652
http://dx.doi.org/10.1186/s13550-023-00993-4

Ejemplares similares